Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-13-000191

President & CEO sold 7,600 shares at an average $39.96 ($303,687)

  • President & CEO acquired 7,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CONCANNON BRIAN · President & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2013-11-01 Exercise or conversion : show line 1 in the form +4,600 $25.54 $117,461 134,907 D
2013-11-01 Sale : show line 2 in the form −4,600 $39.96 $183,806 130,307 D
2013-11-01 Exercise or conversion : show line 3 in the form +3,000 $13.05 $39,158 133,307 D
2013-11-01 Sale : show line 4 in the form −3,000 $39.96 $119,881 130,307 D
Open-market sales · 7,600 sh · avg $39.96 · $303,687

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2013-11-01 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) −3,000 $39.96 $119,881 $13.05 2014-05-05 3,000 9,000 D
2013-11-01 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −4,600 $39.96 $183,806 $25.54 2014-10-24 4,600 41,180 D
Loading xslF345X03/edgardoc.xml…